NAARDEN, The Netherlands--(BUSINESS WIRE)--BAC BV, the leading provider of antibody based affinity purification technology, today announced the addition of a new bioprocess affinity chromatography resin to GE Healthcare Life Sciences' portfolio of custom-designed media. The FactorVII / FactorVIIa resin will be marketed under the name VIISelect and is the latest addition to our series of chromatography media developed for the purification of blood coagulants.
